STATERA BIOPHARMA INC (STAB)
US8575611046 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 506.10K | 1.84M | 1.95M | 1.13M | 3.62M | |||
| Marketable Securities | 0.00 | 134.60K | 324.87K | 452.30K | 503.81K | |||
| Receivables | 361.43K | 348.76K | 11.51K | 378.87K | 251.85K | |||
| Other Current Assets | 345.98K | 1.82M | 31.51K | 45.38K | 103.40K | |||
| Total Current Assets | 1.21M | 4.15M | 2.31M | 2.00M | 4.48M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.02M | 1.17M | 3.72K | 15.51K | 27.75K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 9.27M | 9.27M | N/A | N/A | N/A | |||
| Intangibles | 1.24M | 1.58M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 8.12K | 5.01M | N/A | 18.67K | 30.37K | |||
| Total Non-Current Assets | 11.54M | 17.02M | 3.71K | 34.18K | 58.12K | |||
| TOTAL ASSETS | 12.75M | 21.17M | 2.32M | 2.04M | 4.53M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 6.40M | 4.58M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | N/A | |||
| Accrued Expenses | 6.63M | 2.01M | 136.84K | 1.26M | 772.80K | |||
| Accounts Payable | 8.13M | 3.96M | 167.77K | 263.57K | 139.12K | |||
| Other Current Liabilities | 1.07M | 699.30K | N/A | N/A | N/A | |||
| Total Current Liabilities | 22.23M | 11.25M | 304.61K | 1.52M | 911.92K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 10.63M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 686.20K | 806.20K | 0.00 | 0.00 | 8.46K | |||
| Total Non-Current Liabilities | 759.23K | 11.49M | 4.97M | 5.04M | 5.07M | |||
| TOTAL LIABILITIES | 22.99M | 22.74M | 5.28M | 6.56M | 5.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -144.08M | -129.48M | -169.10M | -167.17M | -164.06M | |||
| Additional Paid In Capital | 133.53M | 127.74M | 166.76M | 163.16M | 163.16M | |||
| Minority Interest | 81.12K | 85.62K | 5.01M | 5.09M | 5.16M | |||
| Common Shares | 253.72K | 177.42K | 66.88K | 56.49K | 56.49K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 53.70K | -6.65K | -685.68K | -568.03K | -611.37K | |||
| Shares Outstanding | 50.74M | 35.48M | 13.38M | 11.30M | 11.30M | |||
| Tangible Book Value per Share | -0.41 | -0.35 | -0.22 | -0.40 | -0.13 | |||
| Total Shareholders' Equity | -10.24M | -1.57M | -2.96M | -4.52M | -1.45M | |||
| TOTAL LIABILITIES AND EQUITY | 12.75M | 21.17M | 2.32M | 2.04M | 4.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -9.69 | N/A | N/A | N/A | |||
| Current Ratio | 0.05 | 0.37 | 7.60 | 1.32 | 4.91 | |||
| Return On Assets (ROA) | -720.30% | -481.12% | -103.47% | -129.96% | -79.66% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD